doi: 10.1016/s0165-0327(97)00159-6.
Pretreatment plasma HVA predicts neuroleptic response in manic psychosis
Affiliations
- PMID:9495606
- DOI: 10.1016/s0165-0327(97)00159-6
Item in Clipboard
Pretreatment plasma HVA predicts neuroleptic response in manic psychosis
C M Mazure et al. J Affect Disord.1998 Feb.
Free article Display options
Format
Display options
Format
Abstract
Elevated pretreatment plasma free homovanillic acid (HVA) predicted acute response to neuroleptic treatment in patients with manic psychosis. These findings suggest that plasma HVA may be a useful predictor of a successful short-term response in manic as well as schizophrenic psychoses, and that elevated pre-synaptic dopaminergic release may play a role in more than one group of psychotic disorders.
Similar articles
- Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.Mazure CM, Nelson JC, Jatlow PI, Bowers MB.Mazure CM, et al.Biol Psychiatry. 1991 Sep 1;30(5):475-82. doi: 10.1016/0006-3223(91)90309-a.Biol Psychiatry. 1991.PMID:1932395
- Plasma catecholamine metabolites and treatment response at neuroleptic steady state.Bowers MB Jr, Swigar ME, Jatlow PI, Hoffman FJ.Bowers MB Jr, et al.Biol Psychiatry. 1989 Mar 15;25(6):734-8. doi: 10.1016/0006-3223(89)90245-x.Biol Psychiatry. 1989.PMID:2923935
- Psychotogenic drug use and neuroleptic response.Bowers MB Jr, Mazure CM, Nelson JC, Jatlow PI.Bowers MB Jr, et al.Schizophr Bull. 1990;16(1):81-5. doi: 10.1093/schbul/16.1.81.Schizophr Bull. 1990.PMID:1970670
- Perspectives on a time-dependent model of neuroleptic action.Pickar D.Pickar D.Schizophr Bull. 1988;14(2):255-68. doi: 10.1093/schbul/14.2.255.Schizophr Bull. 1988.PMID:2904694Review.
- Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients.Pickar D, Breier A, Kelsoe J.Pickar D, et al.Ann N Y Acad Sci. 1988;537:339-46. doi: 10.1111/j.1749-6632.1988.tb42118.x.Ann N Y Acad Sci. 1988.PMID:2904783Review.
Cited by
- GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.Arrúe A, Dávila R, Zumárraga M, Basterreche N, González-Torres MA, Goienetxea B, Zamalloa MI, Anguiano JB, Guimón J.Arrúe A, et al.Neurochem Res. 2010 Feb;35(2):247-53. doi: 10.1007/s11064-009-0048-z. Epub 2009 Aug 22.Neurochem Res. 2010.PMID:19701707
- Interaction of DRD2TaqI, COMT, and ALDH2 genes associated with bipolar II disorder comorbid with anxiety disorders in Han Chinese in Taiwan.Hu MC, Lee SY, Wang TY, Chang YH, Chen SL, Chen SH, Chu CH, Wang CL, Lee IH, Chen PS, Yang YK, Lu RB.Hu MC, et al.Metab Brain Dis. 2015 Jun;30(3):755-65. doi: 10.1007/s11011-014-9637-x. Epub 2014 Nov 29.Metab Brain Dis. 2015.PMID:25430946
- The Phenomenology of Delusions in a Patient with Disorders of Sex Development.Göğcegöz Gül I, Hizli Sayar G, Özten E, Eryilmaz G.Göğcegöz Gül I, et al.Noro Psikiyatr Ars. 2015 Jun;52(2):198-199. doi: 10.5152/npa.2015.7231. Epub 2015 Jun 1.Noro Psikiyatr Ars. 2015.PMID:28360704Free PMC article.
- Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report.Miura I, Kono S, Oshima S, Kanno-Nozaki K, Mashiko H, Niwa S, Yabe H.Miura I, et al.Neuropsychiatr Dis Treat. 2014 Mar 25;10:507-11. doi: 10.2147/NDT.S58302. eCollection 2014.Neuropsychiatr Dis Treat. 2014.PMID:24707175Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical